logo
Select company
Select metric
$ 4.13MInterest Expense
VS
Market
49
Sector
30
Industry
18
History
-
$ 2.14Close
$ 0.9 - $ 3.27 52-Week Range
Ticker Information

Ticker

ABOS

Company Name

ACUMEN PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ACUMEN PHARMACEUTICALS INC - Interest Expense Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ABOS - Int. Exp. Historical data
DateInterest Expense
6/30/2025$ 4.13M
3/31/2025$ 4.09M
12/31/2024$ 4.07M
9/30/2024$ 3.61M
6/30/2024$ 2.58M
3/31/2024$ 1.58M
12/31/2023$ 581K
9/30/2023$ 0
6/30/2023$ 0
3/31/2023$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ACUMEN PHARMACEUTICALS INC's latest trailing twelve months (TTM) Int. Exp. stands at $ 0.
  • Over the past 5 years, ACUMEN PHARMACEUTICALS INC's average Int. Exp. has been $ 1.38M.
  • The median Int. Exp. for ACUMEN PHARMACEUTICALS INC during this period was $ 0
  • ACUMEN PHARMACEUTICALS INC reached its highest Int. Exp. over the past 5 years at $ 4.13M.
  • The lowest Int. Exp. recorded by ACUMEN PHARMACEUTICALS INC in the same timeframe $ -23K

Definition of Interest Expense

[Income Statement] Interest expense is the cost incurred by a business for borrowing funds.

ABOS - Interest Expense, Last 5 years

$ -23K

Minimum

Sep 30, 2022

$ 4.13M

Maximum

Jun 30, 2025

$ 1.38M

Average

$ 0

Median

Int. Exp. Benchmark Analysis

The chart above depicts the distribution of Int. Exp. for companies in the Total Stock Market. The average Int. Exp. of the companies is $ 2.81M with a standard deviation of $ 5.59M.
The following table provides additional summary stats:
Int. Exp. in the Market:
filtered constituents2.73K
min$ -15.41M
max$ 23.09M
average$ 2.81M
median$ 19.42K
std$ 5.59M